MediBeacon Inc.

MediBeacon Inc. is a medical technology company specializing in fluorescent tracer agents and transdermal detection technology for non-invasive physiological monitoring. Their FDA-approved Transdermal GFR System provides point-of-care kidney function assessment, with applications across nephrology, gastroenterology, ophthalmology, and surgery. The company is engaged in clinical and preclinical research to advance fluorescence-based medical diagnostics and monitoring.